News AREV Life Sciences Global Corp.

Equities

AREV

CA04019J1093

Market Closed - Canadian Securities Exchange Other stock markets 12:06:40 2023-07-11 pm EDT			5-day change	1st Jan Change
0.09 ^CAD	-10.00%		-.--%	-.--%

2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AREV Announces Significant Corporate Progress Amid Trading Suspension	Feb. 06	AQ
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 08	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Dec. 08	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	Nov. 28	CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	Nov. 17	CI
CSE Bulletin: Suspensions (AREV, EMER)	23-07-20	NE
Canadian Investment Regulatory Organization Trading Halt - AREV	23-07-20	AQ
Notice Of Default - Update	23-07-10	AQ
Notice of Default - Update	23-05-15	AQ
AREV Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of Traditional Medicine	23-05-09	AQ
AREV Life Sciences Global Corp. Announces Filing of Application for Management Cease Trade Order	23-04-27	AQ
AREV Terminates Private Placement and Term Sheet with Fiberlab, Inc.	23-03-27	AQ
AREV Life Sciences Global Corp. (CNSX : AREV) cancelled the acquisition of Fiberlab, Inc.	23-03-26	CI
AREV Life Sciences Global Corp. cancelled the transaction announced on March 14, 2023	23-03-26	CI
AREV Signs Term Sheet with Fiberlab, Inc.	23-03-15	AQ
AREV Life Sciences Global Corp. (CNSX : AREV) entered into letter on intent to acquire Fiberlab, Inc for $7 million.	23-03-14	CI
AREV Life Sciences Global Corp. announced that it expects to receive CAD 7.548 million in funding	23-03-13	CI
AREV Life Sciences Provides Annual Review for 2022 and Operational Update	23-02-28	AQ
Team from Queensland Brain Institute Identifies New Hericerin Derivitives from Lions Mane that Boost Nerve Growth and Enhances Memory	23-02-15	AQ
Arev Issues Incentive Stock Options	23-01-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AREV Life Sciences Global Corp.

Equities

AREV

CA04019J1093

Summary

Filters